Browsed by
Tag: Manufacturing

CNS Pharmaceuticals begins manufacturing Berubicin in Europe (NASDAQ:CNSP)

CNS Pharmaceuticals begins manufacturing Berubicin in Europe (NASDAQ:CNSP)

CNS Pharmaceuticals’ (NASDAQ:CNSP) European manufacturer, BSP Pharmaceuticals has begun the manufacturing process for Berubicin drug product.

The drug is a lead candidate for the treatment of glioblastoma multiforme or GBM, an aggressive form of brain cancer currently considered incurable.

The company’s focus remains on initiating a U.S. Phase 2 trial for Berubicin in Q1 of 2021.

“With the manufacturing of our Berubicin Drug Product in Europe, we continue to advance closer toward an IND filing for Berubicin, which we expect to submit later this quarter.” says John Climaco, CEO.

Press Release

Source Article Read the rest

CNS Pharmaceuticals Begins Manufacturing of Berubicin in Europe

CNS Pharmaceuticals Begins Manufacturing of Berubicin in Europe

HOUSTON, Oct. 9, 2020 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the Company’s European manufacturer, BSP Pharmaceuticals S.p.A. (“BSP”), has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable.

(PRNewsfoto/CNS Pharmaceuticals, Inc.)

“Our preparations for filing an IND for Berubicin require continued execution in both our clinical and manufacturing initiatives,” stated John Climaco, CEO of CNS Pharmaceuticals. “With the manufacturing of our Berubicin Drug Product in Europe, we continue to advance closer toward an IND filing for Berubicin, which we expect to submit later this quarter.  We have also made significant progress on the clinical front and recently engaged Worldwide Clinical Trials as the contract research organization, Image Analysis Group (“IAG”) as the imaging partner, and Berry Consultants as a biostatistical advisor for our Phase 2 trial design. We have also added Dr. Patrick Wen, a renowned neuro-oncologist, to our Scientific Advisory Board. Our laser focus remains on initiating a U.S. Phase 2 trial for Berubicin in Q1 of 2021 and we continue to demonstrate our ability to execute our operational and clinical plans toward that goal.”

As part of the Company’s plan to mitigate COVID-19-related delay risks, diversify its supply chain and provide for localized availability of Berubicin, the Company implemented a dual-track drug product manufacturing strategy. Under this dual-track strategy, it engaged two separate manufacturers for Berubicin on different continents, both U.S.-based Pharmaceutics International, Inc. (“Pii”) and Italy-based BSP. As previously announced, CNS completed synthesis of Berubicin active pharmaceutical ingredient (API) and shipped API to both Pii and

Read the rest
Electronic Manufacturing Services Market Procurement Intelligence Report with COVID-19 Impact Analysis

Electronic Manufacturing Services Market Procurement Intelligence Report with COVID-19 Impact Analysis

The Electronic Manufacturing Services market will register an incremental spend of about $130 billion, growing at a CAGR of 5.00% during the five-year forecast period. A targeted strategic approach to Electronic Manufacturing Services sourcing can unlock several opportunities for buyers. This report also offers market impact and new opportunities created due to the COVID-19 pandemic. Request free sample pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005793/en/

SpendEdge has announced the release of its Global Electronic Manufacturing Market Procurement Intelligence Report (Graphic: Business Wire)

Key benefits to buy this report:

  • What are the market dynamics?

  • What are the key market trends?

  • What are the category growth drivers?

  • What are the constraints on category growth?

  • Who are the suppliers in this market?

  • What are the demand-supply shifts?

  • What are the major category requirements?

  • What are the procurement best practices in this market?

Information on Latest Trends and Supply Chain Market Information Knowledge centre on COVID-19 impact assessment

SpendEdge’s reports now include an in-depth complimentary analysis of the COVID-19 impact on procurement and the latest market data to help your company overcome sourcing challenges. Our Electronic Manufacturing Services market procurement intelligence report offers actionable procurement intelligence insights, sourcing strategies, and action plans to mitigate risks arising out of the current pandemic situation. The insights offered by our reports will help procurement professionals streamline supply chain operations and gain insights into the best procurement practices to mitigate losses.

Insights into buyer strategies and tactical negotiation levers:

Several strategic and tactical negotiation levers are explained in the report to help buyers achieve the best prices for Electronic Manufacturing Services market. The report also aids buyers with relevant Electronic Manufacturing Services pricing levels, pros and cons of prevalent pricing models such as volume-based pricing, spot pricing, and cost-plus pricing and category

Read the rest
Taiwan Semiconductor Manufacturing Company: An Undervalued Market Leader With A Multi-Year Growth Runway (NYSE:TSM)

Taiwan Semiconductor Manufacturing Company: An Undervalued Market Leader With A Multi-Year Growth Runway (NYSE:TSM)

The Taiwan Semiconductor Manufacturing Company Ltd. (TSM) is the world’s first and largest dedicated semiconductor foundry. It is also the lead player with a market share estimate of between 51.5% and 53.9%. In distant second place is Samsung Electronics (OTC:SSNLF) (OTC:SSNNF), with an estimated 17.4% to 18.8% share of the market. What makes TSMC unique is that it has managed to stay ahead of the pack since it was founded in 1987, and it continues to invest heavily in advanced wafer technologies and processes to maintain its lead and strengthen its position in a growing segment.

Source: Statista

How Big is the Foundry Market and How Fast is TMSC Growing?

The global semiconductor foundry market is projected to grow from around $42 billion in 2019 to over $62 billion in 2025 at a CAGR of 6.75%.

By comparison, TSMC grew its Q2-20 revenue by 28.9% and H1-20 revenue by 35.2%, both over their prior periods in terms of NT$ (New Taiwan dollars.) Although there was a prolonged decline until Q1-19 in quarterly YoY revenue growth, positive growth returned in Q2-19 and double-digit YoY revenue growth has been reported since Q3-19 in NT$ terms. It’s clear that TSMC is outperforming the overall market by a significant margin in recent quarters, specifically in H1-20.

Source: AnandTech

As of H1-20, TSMC had the highest EUV or Extreme Ultraviolet installed base at 50%, as well as 60% of global wafer capacity, which shows its dominance of the semiconductor foundry market.

Short-term Growth Indicators

H2-20 is also shaping up to be a period of strong revenue growth, and there are a couple of reasons for this:

First of all, Apple, Inc. (AAPL) has tapped TSMC’s entire 5nm capacity for its A14 Bionic chip in the upcoming iPhone 12 and other devices, in addition to future

Read the rest